Cadre Holdings Inc (CDRE) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Cadre Holdings inc   (NYSE: CDRE)
 

Cadre Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cadre Holdings Inc inventory turnover ratio, the Cadre Holdings Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 3.39 in the second quarter 2026, yet the ratio remained below the average, as CDRE's market remain challenging.Average inventory processing period, for the Cadre Holdings Inc in Jun 30 2026 quarter, has decreased to 108 days, compare to 111 days, in the Mar 31 2026 quarter.

Within Healthcare sector 112 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 995 in the first quarter 2026, to 1166.

CDRE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cadre Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDRE Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 17.81 % 42.71 % 21.75 % 12.67 % 14.6 %
Y / Y Cost of Sales Growth 30.43 % 30.14 % -2.83 % 28.99 % 7.4 %
Inventory Turnover Ratio (TTM) 3.39 3.28 3.38 3.56 3.47
CDRE's Total Ranking # 1166 # 995 # 833 # 644 # 907
Average inventory processing period 108 111 108 102 105
Seq. Inventory Growth -1.43 % 30.65 % -10.64 % 2.37 % 19.41 %
Seq. Cost of Sales Growth 26.31 % -1.04 % 7.87 % -3.26 % 26.03 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 45
Healthcare Sector # 113
Overall Market # 1166

Inventory Turnover Ratio Statistics
High Average Low
3.83 3.56 3.28
(Mar 31 2022)   (Mar 31 2026)



CDRE Company Profile >> Back to CDRE Efficiency Comparisons >> Compare CDRE Inventory Turnover Ratio to its Competitors

Financial Statements
Cadre Holdings Inc 's Inventories $ 129 Millions Visit CDRE's Balance sheet
Cadre Holdings Inc 's Cost of Revenues TTM $ 400 Millions Visit CDRE's Income Statement
What are CDRE's Sales? Visit CDRE's Sales by Segment

Other Inventory Turnover Ratios
Cadre Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CDRE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CDRE's Competitors
Inventory Turnover Ratio for CDRE's Suppliers
Inventory Turnover Ratio for CDRE's Customers

You may also want to know
CDRE's Sales Growth Rates CDRE's Pe Price to earnings ratio CDRE's Receivables Turnover Ratio CDRE's Stock Quote
CDRE's Net Income Growth Rates CDRE's Ps Price to Sales ratio CDRE's Sales per Employee CDRE's Asset Turnover Ratio
CDRE's Net Margin CDRE's Pb Price to Book ratio CDRE's Financial Strength Ratios CDRE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Edap Tms Sa  6.05 $ 60.703  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions

Date modified: 2026-09-11T10:05:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.